Patent Assignment
Reel/Frame 073529/0982
Assignment of Assignor's Interest
Recorded: 2026-01-21
Pages: 6
Assignee
PRINCIPIA BIOPHARMA INC.
100 MORRIS STREET, MORRISTOWN, NEW JERSEY, 09760
Covered Properties
(2)
Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
PCT:
PCT/US2023/078211 ↗
Methods for Treating Immune Thrombocytopenia By Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enentrile
Application:
19/194,148 →
Publication:
US 2025/0255874
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.